Emad Shash, Leading Cancer Researcher and Director at National Cancer Institute, Cairo University, shared a post on LinkedIn:
“March is always a meaningful time to reflect on women’s health, dignity, and empowerment.
In breast cancer care, success is not defined only by diagnosis, treatment plans, or survival outcomes. It is also defined by how well we help women live through treatment, preserve their quality of life, and remain able to continue therapies that matter.
I am pleased to share our narrative review, ‘Non-hormonal treatments for hot flashes in breast cancer patients: a narrative review,’ published in Future Journal of Pharmaceutical Sciences.
Hot flashes are often underestimated, yet for many women receiving endocrine therapy they represent a major daily burden, affecting sleep, emotional well-being, daily functioning, and sometimes adherence to treatment. Our review highlights the importance of evidence-based non-hormonal strategies, including behavioral approaches and pharmacologic options, while emphasizing the need for individualized care and careful consideration of drug interactions.
This March, the message is clear: advancing women’s health means going beyond disease control alone. It means addressing the symptoms that shape everyday life, strengthening survivorship, and making cancer care more humane, more thoughtful, and more complete.
Proud to have contributed to this work with my co-authors: Prof. Hayam Ateyya, Prof. Nouran Omar, PhD and Dr. Fatma Abdalkarim.”
Title: Non-hormonal treatments for hot flashes in breast cancer patients: a narrative review.
Authors: Fatma Abdalkarim Ibrahim, Nouran Omar El Said, Emad Shash and Hayam Ateyya
Read The Full Article:
Other articles featuring Emad Shash on OncoDaily.